{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,2]],"date-time":"2025-08-02T19:13:53Z","timestamp":1754162033444,"version":"3.41.2"},"reference-count":6,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"7","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1097\/mca.0000000000001269","type":"journal-article","created":{"date-parts":[[2023,10,6]],"date-time":"2023-10-06T03:00:53Z","timestamp":1696561253000},"page":"520-521","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Impact of bivalirudin with a post-procedure infusion versus heparin-monotherapy on stent thrombosis and cardiovascular mortality"],"prefix":"10.1097","volume":"34","author":[{"given":"Rahman","family":"Shah","sequence":"first","affiliation":[{"name":"Department of Cardiovascular Medicine, Methodist Le Bonheur Healthcare, University of Tennessee, Memphis, Tennessee, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2023,7,28]]},"reference":[{"key":"R1-20250729","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.ahj.2015.10.006","article-title":"An updated comprehensive meta-analysis of bivalirudin vs heparin use in primary percutaneous coronary intervention.","volume":"171","author":"Shah","year":"2016","journal-title":"Am Heart J"},{"key":"R2-20250729","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1016\/j.jcin.2016.03.031","article-title":"Effect of post-primary percutaneous coronary intervention bivalirudin infusion on acute stent thrombosis: meta-analysis of randomized controlled trials.","volume":"9","author":"Shah","year":"2016","journal-title":"JACC Cardiovasc Interv"},{"key":"R3-20250729","first-page":"e4","article-title":"2021 ACC\/AHA\/SCAI guideline for coronary artery revascularization: executive summary: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines.","volume":"145","author":"Lawton","year":"2022","journal-title":"Circulation"},{"key":"R4-20250729","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1016\/S0140-6736(22)01999-7","article-title":"Bivalirudin plus a high-dose infusion versus heparin monotherapy in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: a randomised trial.","volume":"400","author":"Li","year":"2022","journal-title":"Lancet"},{"key":"R5-20250729","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1002\/jrsm.12","article-title":"A basic introduction to fixed-effect and random-effects models for meta-analysis.","volume":"1","author":"Borenstein","year":"2010","journal-title":"Res Synth Methods"},{"key":"R6-20250729","first-page":"210","article-title":"Bivalirudin with a post-procedure infusion versus heparin monotherapy for the prevention of stent thrombosis.","volume":"94","author":"Shah","year":"2019","journal-title":"Catheter Cardiovasc Interv"}],"container-title":["Coronary Artery Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MCA.0000000000001269","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,29]],"date-time":"2025-07-29T18:03:37Z","timestamp":1753812217000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MCA.0000000000001269"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,28]]},"references-count":6,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1097\/mca.0000000000001269","relation":{},"ISSN":["0954-6928"],"issn-type":[{"type":"print","value":"0954-6928"}],"subject":[],"published":{"date-parts":[[2023,7,28]]}}}